Oxidatively modified fatty acyl chain determines physicochemical properties of aggregates of oxidized phospholipids

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 3, 2010, Pages 442-452

  Pande, Abhay H ^a   Kar, Subhabrata ^a   Tripathy, Rajan K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Anisotropy; Critical micelle concentration; Generalized polarization; Microfluidity; Micropolarity; Stokes diameter; Surface potential

Indexed keywords

1 PALMITOYL 2 (5' OXO VALEROYL) SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 (9' OXO NONANOYL) SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 AZELAOYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 GLUTAROYL SN GLYCERO 3 PHOSPHOCHOLINE; PHOSPHOLIPID DERIVATIVE; TRUNCATED OXIDIZED PHOSPHOLIPID; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; AQUEOUS SOLUTION; ARTICLE; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; FLUORESCENCE SPECTROSCOPY; GEL PERMEATION CHROMATOGRAPHY; LIPID ANALYSIS; LIPID COMPOSITION; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

2-NAPHTHYLAMINE; ANILINO NAPHTHALENESULFONATES; ANISOTROPY; CHROMATOGRAPHY, GEL; DIPHENYLHEXATRIENE; ELECTROPHORESIS, AGAR GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FATTY ACIDS; LAURATES; MICELLES; MOLECULAR PROBES; OXAZINES; OXIDATION-REDUCTION; PHOSPHOLIPIDS; PHYSICOCHEMICAL PHENOMENA; SPECTROMETRY, FLUORESCENCE;

EID: 77049086521     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.12.028     Document Type: Article

References (51)

1. Catalá A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 157 (2009) 1-11
2. Fruhwirth G.O., Loidl A., and Hermetter A. Oxidized phospholipids: from molecular properties to disease. Biochim. Biophys. Acta 1772 (2007) 718-736
3. Deigner H.P., and Hermetter A. Oxidized phospholipids: emerging lipid mediators in pathophysiology. Curr. Opin. Lipidol. 19 (2008) 289-294
4. Fruhwirth G.O., and Hermetter A. Mediation of apoptosis by oxidized phospholipids. In: Quinn P.J., and Wang X. (Eds). Lipids in Health and Disease (2000), Springer, Netherlands 351-367
5. Sabatini K., Mattila J.P., Megli F.M., and Kinnunen P.K.J. Characterization of two oxidatively modified phospholipids in mixed monolayers with DPPC. Biophys. J. 90 (2006) 4488-4499
6. Bach D., Epand R.F., Epand R.M., Miller I.R., and Wachtel E. The oxidized form of cholesterol 3beta-hydroxy-5-oxo-5, 6-secocholestan-6-al induces structural and thermotropic changes in phospholipid membranes. Chem. Phys. Lipids 161 (2009) 95-102
7. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007) 44-84
8. Fu P., and Birukov K.G. Oxidized phospholipids in control of inflammation and endothelial barrier. Transl. Res. 153 (2009) 166-176
9. Reichardt C. Solvatochromic dyes as solvent polarity indicators. Chem. Rev. 94 (1994) 2319-2358
10. Pérusse M., Pascot A., Després J.-P., Couillard C., and Lamarche B. A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma. J. Lipid Res. 42 (2001) 1331-1334
11. Litman B.J. Lipid model membranes. Characterization of mixed phospholipid vesicles. Biochemistry 12 (1973) 2545-2554
12. Megli F.M., Russo L., and Conte E. Spin labeling EPR studies of the properties of oxidized phospholipid-containing lipid vesicles. Biochim. Biophys. Acta 1788 (2009) 371-379
13. Sparks D.L., and Phillips M.C. Quantitative measurement of lipoprotein surface charge by agarose gel electrophoresis. J. Lipid Res. 33 (1992) 123-130
14. Sheetz M.P., and Chan S.I. Effect of sonication on the structure of lecithin bilayer. Biochemistry 11 (1972) 4573-4581
15. Huang C., and Mason J.T. Geometric packing constraint in egg phosphatidylcholine vesicles. Proc. Natl. Acad. Sci. 75 (1978) 308-310
16. De Vendittis E., Palumbo G., Parlato G., and Bocchini V. A fluorimetric method for the estimation of the critical micelle concentration of surfactants. Anal. Biochem. 115 (1981) 278-286
17. Parasassi T., De Stasio G., Ravagnan G., Rusch R.M., and Gratton E. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys. J. 60 (1991) 179-189
18. Lakowicz J.R. Fluorescence anisotropy. Principles of fluorescence spectroscopy. 3 rd ed. (2006), Kluwer Academic/Plenum Publishers, New York 353-382
19. Asai Y., Nomura T., Murahashi N., and Iwamoto K. Characterization of the physicochemical properties of the micelles of platelet-activating factor (C18:0). Drug Dev. Ind. Pharm. 26 (2000) 671-674
20. Nguyen S.D., and Sok D.-E. Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position. Biochim. Biophy. Acta 1758 (2006) 499-508
21. Chromy B.A., Arroyo E., Blanchette C.D., Bench G., Benner H., Cappuccio J.A., Coleman M.A., Henderson P.T., Hinz A.K., Kuhn E.A., Pesavento J.B., Segelke B.W., Sulchek T.A., Tarasow T., Walsworth V.L., and Hoeprich P.D. Different apolipoproteins impact nanolipoprotein particle formation. J. Am. Chem. Soc. 129 (2007) 14348-14354
22. Alonso A., Sáez R., and Goñi F.M. The interaction of detergents with phospholipid vesicles: a spectrofluorimetric study. FEBS Lett. 11 (1982) 141-145
23. De Vequi-Suplicy C.C., Benatti C.R., and Lamy M.T. Laurdan in fluid bilayers: position and structural sensitivity. J. Fluoresc. 16 (2006) 431-439
24. Lentz B.R. Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. Chem. Phys. Lipids 64 (1993) 99-116
25. Greenspan P., and Fowler S.D. Spectrofluorometric studies of the lipid probe, Nile red. J. Lipid Res. 26 (1985) 781-789
26. Fujii H., Kawai T., and Nishikawa H. Determination of pH in reversed micelles. Bull. Chem. Soc. Jpn. 52 (1979) 2051-2055
27. Abuin E.B., Lissi E.A., Aspee A., Gonzalez F.D., and Varas J.M. Fluorescence of 8-anilinonaphthalene-1-sulfonate and properties of sodium dodecyl sulfate micelles in water-urea mixtures. J. Colloid Interface Sci. 186 (1997) 332-338
28. Slavík J. Anilinonaphthalene sulfonate as a probe of membrane composition and function. Biochim. Biophys. Acta 694 (1982) 1-25
29. Paternostre M., Meyer O., Grabielle-Madelmont C., Lesieur S., Ghanam M., and Ollivon M. Partition coefficient of a surfactant between aggregates and solution: application to the micelle-vesicle transition of egg phosphatidylcholine and octyl beta-D-glucopyranoside. Biophys. J. 69 (1995) 2476-2488
30. Krasnowska E.K., Gratton E., and Parasassi T. Prodan as a membrane surface fluorescence probe: partitioning between water and phospholipid phases. Biophys. J. 74 (1998) 1984-1993
31. Parasassi T., Krasnowska E.K., Bagatolli L., and Gratton E. Laurdan and Prodan as polarity-sensitive fluorescent membrane probes. J. Fluoresc. 8 (1998) 365-373
32. Shinitzky M., and Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim. Biophys. Acta 515 (1978) 367-394
33. Nomura T., Asai Y., Murahashi N., and Iwamoto K. Formation of spherical micelles by the novel platelet activating factor receptor antagonist, E5880. Chem. Pharm. Bull. (Tokyo) 48 (2000) 947-950
34. Zhang X., Jackson J.K., and Burt H.M. Determination of surfactant critical micelle concentration by a novel fluorescence depolarization technique. J. Biochem. Biophys. Methods 31 (1996) 145-150
35. Lesieur S., Grabielle-Madelmont C., Patemostre M., and Ollivon M. Size analysis and stability study of lipid vesicles by high performance gel exclusion chromatography, turbidity, and dynamic light scattering. Anal. Biochem. 192 (1991) 334-343
36. Huang C., Mason J.T., Stephenson F.A., and Levin I.W. Polymorphic phase behavior of platelet-activating factor. Biophys J. 49 (1986) 587-595
37. Mattila J.P., Sabatini K., and Kinnunen P.K.J. Oxidized phospholipids as potential novel drug targets. Biophys. J. 93 (2007) 3105-3112
38. Greenberg M.E., Li X.M., Gugiu B.G., Gu X., Qin J., Salomon R.G., and Hazen S.L. The lipid whisker model of the structure of oxidized cell membranes. J. Biol. Chem. 283 (2008) 2385-2396
39. Khandelia H., and Mouritsen O.G. Lipid gymnastics: evidence of complete acyl chain reversal in oxidized phospholipids from molecular simulations. Biophys. J. 96 (2009) 2734-2743
40. Israelachvili J.N. Intermolecular and Surface Forces: With Application to Colloidal and Biological Systems (1985), Academic Press, London
41. Megli F.M., and Russo L. Different oxidized phospholipid molecules unequally affect bilayer packing. Biochim. Biophys. Acta. 1778 (2008) 143-152
42. Mattila J.P., Sabatini K., and Kinnunen P.K. Interaction of cytochrome c with 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine: evidence for acyl chain reversal. Langmuir 24 (2008) 4157-4160
43. Mattila J.P., Sabatini K., and Kinnunen P.K. Oxidized phospholipids as potential molecular targets for antimicrobial peptides. Biochim. Biophys. Acta. 1778 (2008) 2041-2050
44. Epand R.F., Mishra V.K., Palgunachari M.N., Anantharamaiah G.M., and Epand R.M. Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids. Biochim. Biophys. Acta 1788 (2009) 1967-1975
45. Chen R., Yang L., and McIntyre T.M. Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade. J. Biol. Chem. 282 (2007) 24842-24850
46. Bergmark C., Dewan A., Orsoni A., Merki E., Miller E.R., Shin M.J., Binder C.J., Hörkkö S., Krauss R.M., Chapman M.J., Witztum J.L., and Tsimikas S. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J. Lipid Res. 49 (2008) 2230-2239
47. van Lenten B.J., Wagner A.C., Anantharamaiah G.M., Navab M., Reddy S.T., Buga G.M., and Fogelman A.M. Apolipoprotein A-I mimetic peptides. Curr. Atheroscler. Rep. 11 (2009) 52-57
48. van Lenten B.J., Wagner A.C., Jung C.L., Ruchala P., Waring A.J., Lehrer R.I., Watson A.D., Hama S., Navab M., Anantharamaiah G.M., and Fogelman A.M. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J. Lipid Res. 49 (2008) 2302-2311
49. Troutt J.S., Alborn W.E., Mosior M.K., Dai J., Murphy A.T., Beyer T.P., Zhang Y., Cao G., and Konrad R.J. An apolipoprotein A-I mimetic dose dependently increases the formation of preb1 HDL in human plasma. J. Lipid Res. 49 (2008) 581-587
50. Pande A.H., and Tripathy R.K. Preferential binding of apolipoprotein E derived peptides with oxidized phospholipid. Biochem. Biophys. Res. Commun. 380 (2009) 71-75
51. http://virtual.yosemite.cc.ca.us/smurov/orgsoltab.htm (Accessed on 8th Dec, 2009).